Pharmaceuticals (65) | Sales Agreements (65)

Browse by Company

Recent Contracts

Master Manufacturing and Supply Agreement, dated August 16, 2018, by and between DPT Laboratories, Ltd. and EPI Health, LLC (as successor-in-interest to Allergan Sales, LLC) (Novan, Inc., Filed With SEC on May 16, 2022)
Amendment No. 1 to the Sales Agreement, dated May 13, 2022, by and between the Registrant and SVB Securities LLC (Trevi Therapeutics, Inc., Filed With SEC on May 16, 2022)
Sales Agreement - 6220 E. Dyer Santa Ana (Terra Tech Corp., Filed With SEC on April 15, 2022)
Sales Agreement dated as of March 17, 2022, by and between the Company and Cowen and Company, LLC (Aerpio Pharmaceuticals, Inc., Filed With SEC on March 17, 2022)
Sales Agreement, dated as of December 17, 2021, by and between the Company and Roth Capital Partners, LLC (Assertio Holdings, Inc., Filed With SEC on March 10, 2022)
Sales Agreement, dated as of March 3, 2022, by and between Tilray Brands, Inc. and Jefferies LLC and Canaccord Genuity LLC (Tilray, Inc., Filed With SEC on March 3, 2022)
Sales Agreement dated March 1, 2022, by and between Axsome Therapeutics, Inc. and SVB Securities LLC (Axsome Therapeutics, Inc., Filed With SEC on March 1, 2022)
Controlled Equity OfferingSM Sales Agreement dated January 10, 2022 by and among Agile Therapeutics, Inc. and Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (AGILE THERAPEUTICS INC, Filed With SEC on January 10, 2022)
Sales Agreement dated December 28, 2021 between the Registrant and ThinkEquity LLC (ProPhase Labs, Inc., Filed With SEC on December 29, 2021)
Amendment No. 1 to the At Market Issuance Sales Agreement, dated December 27, 2021, by and between Cumberland Pharmaceuticals Inc. and B. Riley Securities, Inc. (formerly B. Riley... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on December 27, 2021)